In this video

Novartis acquires The Medicines Company for $9.7 billion

Name: Novartis acquires The Medicines Company for $9.7 billion
Uploaded: 2019-11-25T13:39:06.000Z
Duration: 5 min 34 s
Description: Swiss drug maker Novartis is betting on drugs to treat heart disease. The company is acquiring cholesterol drug maker "The Medicines Company" for $9.7 billion. John Maraganore, CEO of Alnylam Pharmaceuticals, joins "Squawk Box" to discuss.

Swiss drug maker Novartis is betting on drugs to treat heart disease. The company is acquiring cholesterol drug maker "The Medicines Company" for $9.7 billion. John Maraganore, CEO of Alnylam Pharmaceuticals, joins "Squawk Box" to discuss.

05:34

Mon, Nov 25 20198:39 AM EST